Ratios
10-year key figure history for Arcede Pharma turnover, profit, dividend, equity, PE and PB.
Stockprice
Price movement for Arcede Pharma with index and moving average MA50 and MA200.
Description
Arcede is developing candidates for new effective drugs for chronic obstructive pulmonary disease (COPD) and severe asthma. The company also owns intellectual property rights for a method of diagnosing cardiovascular disease. The company's business concept is to develop candidates for new drugs based on the patent-pending substance, which in preclinical studies has shown superior results compared with what is currently considered standard treatment. RCD405, the company's main project, is a drug candidate under development primarily for the treatment of chronic obstructive pulmonary disease (COPD).